Seagen
SGEN
#563
Rank
HK$337.15 B
Marketcap
HK$1,787
Share price
-0.07%
Change (1 day)
69.38%
Change (1 year)

Earnings for Seagen (SGEN)

Earnings in 2023 (TTM): -HK$6.2 Billion

According to Seagen 's latest financial reports the company's current earnings are HK$2.30 Billion. In 2022 the company made an earning of -HK$4.79 Billion, an increase over its 2021 earnings that were of -HK$5.33 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Seagen from 2001 to 2023

Annual earnings

Year Earnings Change
2023 (TTM) -HK$6.2 Billion29.32%
2022 -HK$4.79 Billion-10.13%
2021 -HK$5.33 Billion-214.28%
2020 HK$4.66 B-370.63%
2019 -HK$1.73 Billion-15.17%
2018 -HK$2.04 Billion32.79%
2017 -HK$1.53 Billion37.19%
2016 -HK$1.12 Billion18%
2015 -HK$0.95 Billion56.34%
2014 -HK$0.61 Billion23.07%
2013 -HK$0.5 Billion
2011 -HK$1.13 Billion111.72%
2010 -HK$0.54 Billion-19.63%
2009 -HK$0.67 Billion-7.55%
2008 -HK$0.72 Billion64.95%
2007 -HK$0.44 Billion38.4%
2006 -HK$0.32 Billion25.36%
2005 -HK$0.26 Billion-14.86%
2004 -HK$0.3 Billion61.92%
2003 -HK$0.19 Billion-7.67%
2002 -HK$0.2 Billion6.76%
2001 -HK$0.19 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
HK$92.59 B-1,599.16%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
HK$12.96 B-309.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
HK$14.87 B-340.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$62.75 B-1,116.09%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
HK$72.83 B-1,279.25%๐Ÿ‡ฌ๐Ÿ‡ง UK
Spectrum Pharmaceuticals
SPPI
-HK$0.49 Billion-92.17%๐Ÿ‡บ๐Ÿ‡ธ USA
ImmunoGen
IMGN
-HK$0.5 Billion-92.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-HK$2.01 Billion-67.59%๐Ÿ‡บ๐Ÿ‡ธ USA